Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.

Abstract:

BACKGROUND:An oncogeriatric approach may affect management of elderly patients with breast cancer. However, little is known about oncogeriatric care in the metastatic setting. Therefore, we performed an international comparison of management of elderly patients with primary metastatic disease who were treated in two different care settings. MATERIALS AND METHODS:Patients who were ≥70years at diagnosis of primary metastatic disease were eligible. The first cohort comprised a population-based cohort of 104 patients (Comprehensive Cancer Center West, The Netherlands), who all received standard care. The second cohort comprised a hospital-based cohort of 42 patients (H. Lee Moffitt Cancer Center, Florida, United States), who all received oncogeriatric care. RESULTS:No large differences in patient and tumor characteristics were observed between both cohorts. Most patients in the standard care cohort received systemic therapy as primary therapy, whereas most patients in the oncogeriatric cohort received a combination of systemic and local therapy. Patients in the standard care cohort received fewer lines of treatment (mean number of treatments 2.1 vs. 3.6, p<0.001), and particularly received less breast surgery, chemotherapy, and trastuzumab. Three-year overall mortality was 71% (95% CI: 61-83%) as compared to 58% (95% CI: 42-75%) among patients in the oncogeriatric care cohort (multivariable HR: 1.59 [95% CI: 0.88-2.87], p=0.125). CONCLUSIONS:In primary metastatic breast cancer, oncogeriatric care intensifies treatment and might improve survival in elderly patients. Future studies on a larger scale should investigate the potential for improved survival, and whether this is accompanied by a better (preservation of) quality of life and functional status.

journal_name

J Geriatr Oncol

authors

van de Water W,Bastiaannet E,Egan KM,de Craen AJ,Westendorp RG,Balducci L,van de Velde CJ,Liefers GJ,Extermann M

doi

10.1016/j.jgo.2014.02.005

subject

Has Abstract

pub_date

2014-07-01 00:00:00

pages

252-9

issue

3

eissn

1879-4068

issn

1879-4076

pii

S1879-4068(14)00041-1

journal_volume

5

pub_type

杂志文章,多中心研究
  • Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.

    abstract:OBJECTIVES:The purpose of this study was to develop a new brief, comprehensive geriatric assessment scale for older patients diagnosed with different hematological malignancies, the Geriatric Assessment in Hematology (GAH scale), and to determine its psychometric properties. MATERIALS AND METHODS:The 30-item GAH scale...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2015.03.003

    authors: Bonanad S,De la Rubia J,Gironella M,Pérez Persona E,González B,Fernández Lago C,Arnan M,Zudaire M,Hernández Rivas JA,Soler A,Marrero C,Olivier C,Altés A,Valcárcel D,Hernández MT,Oiartzabal I,Fernández Ordoño R,Arnao M,

    更新日期:2015-09-01 00:00:00

  • The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer.

    abstract:OBJECTIVE:Sarcopenia is associated with poor outcomes in patients undergoing surgery for pancreatic ductal adenocarcinoma (PDAC). However, few studies have assessed changes in sarcopenia during multimodality therapy or its effect on overall survival (OS). METHODS:Computed tomography (CT) total psoas area index (TPAI) ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.03.002

    authors: Benjamin AJ,Buschmann MM,Zhang SQ,Wroblewski K,Kindler HL,Roggin KK,Dale W

    更新日期:2018-07-01 00:00:00

  • Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.

    abstract::BACKGROUND: The current study was undertaken to explore whether older age predicts adverse event rates in metastatic melanoma patients participating in cancer clinical trials. METHODS: Six phase II studies conducted at our institution for patients with metastatic disease were used in these pooled analyses: 1) ABT-510...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.04.002

    authors: Jatoi A,Allred JB,Suman VJ,Creagan ET,Croghan GA,Amatruda T,Markovic SN

    更新日期:2012-10-01 00:00:00

  • Envisioning Arti's 'Cadillac study' to assess aging trajectories in cancer survivors.

    abstract::The "Cadillac Study" was the term Arti Hurria, MD often used to articulate her vision of the optimal study to investigate the effects of cancer and its treatments on aging trajectories. In her opinion, this study needed to be designed for near-term clinical translation and have the ability to discern subpopulations of...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.06.009

    authors: Guida JL,Green PA,Gallicchio L

    更新日期:2020-03-01 00:00:00

  • New Treatment Approaches for Older Adults with Multiple Myeloma.

    abstract::The incidence of multiple myeloma (MM) increases with age, and with the aging of the population, the number of adults with MM is expected to double in the next 20 years. Novel agents, including the immunomodulatory agents thalidomide and lenalidomide, and the proteosome inhibitor bortezomib have dramatically changed t...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.02.001

    authors: Wildes TM,Vij R,Petersdorf SH,Medeiros BC,Hurria A

    更新日期:2012-07-01 00:00:00

  • Predictive value of each geriatric assessment domain for older patients with cancer: A systematic review.

    abstract:BACKGROUND:A geriatric assessment (GA) is increasingly used to help guide treatment decisions in older patients with cancer. However, there is no consensus regarding which domains should be included in the GA. In addition, the field of geriatric oncology moves very fast and as a result many new studies have been publis...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.02.010

    authors: Bruijnen CP,van Harten-Krouwel DG,Koldenhof JJ,Emmelot-Vonk MH,Witteveen PO

    更新日期:2019-11-01 00:00:00

  • The geriatrician's perspective on practical aspects of the multidisciplinary care of older adults with cancer.

    abstract::Multidisciplinary teams (MDTs) have been incorporated into the practical care of elderly patients with cancer. Several geriatric oncology centres have attempted to determine the best way to implement MDTs by using geriatric assessment (GA). Developing a geriatric oncology service is a feasible work, which requires sig...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2016.07.001

    authors: Karnakis T,Gattás-Vernaglia IF,Saraiva MD,Gil-Junior LA,Kanaji AL,Jacob-Filho W

    更新日期:2016-09-01 00:00:00

  • Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.

    abstract:BACKGROUND:Adjuvant! Online is a tool used for clinical decision making in patients with early stage colon cancer. As details of the tool's construction are not published, the ability of Adjuvant! Online to accurately predict outcomes for older patients (age 70+) with node positive colon cancer receiving adjuvant chemo...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.07.002

    authors: Papamichael D,Renfro LA,Matthaiou C,Yothers G,Saltz L,Guthrie KA,Van Cutsem E,Schmoll HJ,Labianca R,André T,O'Connell M,Alberts SR,Haller DG,Kountourakis P,Sargent DJ,Adjuvant Colon Cancer Endpoints (ACCENT) Group.

    更新日期:2016-11-01 00:00:00

  • Treatment of older patients with advanced non-small cell lung cancer: A challenge.

    abstract::With a median age of 70 years at diagnosis, lung cancer is a disease of older persons. As a consequence oncologists are confronted with an increasing older lung cancer population for which treatment decisions are needed. In the past years, the therapeutic landscape of advanced non-small cell lung cancer (NSCLC) has ch...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.09.008

    authors: Decoster L,Schallier D

    更新日期:2019-07-01 00:00:00

  • Behavioral, psychological, and supportive care interventions in geriatric oncology: The Cancer and Aging Research Group infrastructure core.

    abstract::Current research efforts focusing on improving outcomes of older adults with cancer lack the appropriate infrastructure to support this growing need. The Cancer and Aging Group R21/33 National Institute of Health (NIH)/National Institute of Aging (NIA) grant aims to support development of geriatric oncology research t...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.019

    authors: Elias R,Loh KP,Targia V,Whitehead M,Canin B,Jatoi A,Loscalzo M,Mohile S

    更新日期:2020-03-01 00:00:00

  • Detection of frailty in elderly cancer patients: Improvement of the G8 screening test.

    abstract:OBJECTIVE:The G8 is a screening test to identify frail elderly patients with cancer. Objectives were to design and evaluate the performance of alternative tests taking into account other predictive domains for frailty. METHODS:We conducted a literature review to identify predictive factors of frailty. Using a Delphi c...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.01.004

    authors: Petit-Monéger A,Rainfray M,Soubeyran P,Bellera CA,Mathoulin-Pélissier S

    更新日期:2016-03-01 00:00:00

  • Patient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications among Older Adults with Cancer.

    abstract::OBJECTIVES: To identify patient characteristics associated with polypharmacy and inappropriate medication (PIM) use among older patients with newly diagnosed cancer. DESIGN: Cross-Sectional Study. SETTING: Ambulatory oncology clinics at an academic medical center. PARTICIPANTS: 117 patients aged ≥ 65 years with new...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.02.005

    authors: Prithviraj GK,Koroukian S,Margevicius S,Berger NA,Bagai R,Owusu C

    更新日期:2012-07-01 00:00:00

  • Management and supportive treatment of frail patients with metastatic pancreatic cancer.

    abstract::Data regarding management of frail patients with pancreatic ductal adenocarcinoma practice is currently very scarce. Randomized clinical trials usually exclude these subgroup of patients and the majority of the publications only consider chronological age and ECOG performance status for their classification. Therefore...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.06.005

    authors: Macarulla T,Carrato A,Díaz R,García A,Laquente B,Sastre J,Álvarez R,Muñoz A,Hidalgo M

    更新日期:2019-05-01 00:00:00

  • Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases.

    abstract:PURPOSE:Older patients with brain metastases (BM) are often excluded from clinical trials. The aim of our study was to investigate the outcomes following Gamma Knife radiosurgery (GKRS) in young old (65-74 years) and very old (≥75 years) patients with BM. METHODS:Between October 2012 and October 2018, we treated 89 pa...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.03.009

    authors: Desideri I,Becherini C,Visani L,Stocchi G,Scoccimarro E,Mariotti M,Salvestrini V,Scoccianti S,Greto D,Bonomo P,Pecchioli G,Bordi L,Della Puppa A,Francolini G,Meattini I,Livi L

    更新日期:2020-09-01 00:00:00

  • Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer.

    abstract:INTRODUCTION:Older adults are underrepresented in landmark trials that determine treatment guidelines for pancreatic cancer. We used the National Cancer Database (NCDB) to compare treatment patterns and outcomes in stage I-III pancreatic cancer between older adult patients, defined as age 80 or older, to patients young...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.12.006

    authors: Li R,Vazquez J,Novak J,Sedrak M,Warner S,Glaser S,Chen YJ,Dale W,Amini A

    更新日期:2020-05-01 00:00:00

  • Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

    abstract:OBJECTIVES:To investigate changes in inflammatory biomarkers during induction therapy for older adults with acute myeloid leukemia (AML) and their associations with geriatric assessment (GA) measures and outcomes. METHODS:This was a single institution ancillary study to a prospective observational study (N = 20 consec...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.03.014

    authors: Loh KP,Tooze JA,Nicklas BJ,Kritchevsky SB,Williamson JD,Ellis LR,Powell BL,Pardee TS,Goyal NG,Klepin HD

    更新日期:2020-04-01 00:00:00

  • Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.

    abstract:BACKGROUND:Screening tools are used in geriatric oncology to determine who should receive a Comprehensive Geriatric Assessment (CGA). However, in this prospective study, we evaluated the association between geriatric screening results, measured with the G8 and Groningen Frailty Indicator (GFI), and severe treatment tox...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2013.12.004

    authors: Baitar A,Van Fraeyenhove F,Vandebroek A,De Droogh E,Galdermans D,Mebis J,Schrijvers D

    更新日期:2014-04-01 00:00:00

  • Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.

    abstract:OBJECTIVE:Clinical trials investigating breast cancer treatment often exclude or misrepresent older adults. This study compares treatment patterns and survival of older women diagnosed with breast cancer between a Dutch and a British observational cohort. MATERIALS AND METHODS:Women aged 70 years and older diagnosed w...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.05.004

    authors: Schuil H,Derks M,Liefers GJ,Portielje J,van de Velde C,Syed B,Green A,Ellis I,Cheung KL,Bastiaannet E

    更新日期:2018-11-01 00:00:00

  • Using heat maps to assess the multidimensional association of comorbidities with survival in older cancer patients treated with chemotherapy.

    abstract:OBJECTIVE:To date, most comorbidity studies have analyzed either a subgroup of frequent diseases, or used summary instruments such as the Charlson score or the Cumulative Illness Rating Scale-Geriatric (CIRS-G). Yet, comorbidity is a multidimensional construct and impacts function, treatment tolerance, and survival. We...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.07.005

    authors: Lee JJ,Kim J,Sehovic M,Chen L,Extermann M

    更新日期:2017-09-01 00:00:00

  • Benefits of minimally-invasive surgery for sigmoid and rectal cancer in older adults compared with younger adults: Do older adults have the most to gain?

    abstract:INTRODUCTION:Randomized trials demonstrated oncologic safety and short-term benefits of laparoscopy. We investigated if the benefit of laparoscopy on short-term outcomes is greater for older adults compared with younger adults. METHODS:We identified all older (≥70 years old) and younger (<70) adults with primary sigmo...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.09.018

    authors: Chesney TR,Quereshy HA,Draginov A,Chadi SA,Quereshy FA

    更新日期:2020-06-01 00:00:00

  • Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: A systematic review of the literature focused on the elderly.

    abstract::Studies on cancer survival have revealed disparities not only between the elderly and their younger counterparts, but also among the elderly themselves. The aim of this work was to identify sociodemographic, socioeconomic, clinical, and care-related determinants of survival or mortality in older patients with cancer b...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.07.007

    authors: Galvin A,Delva F,Helmer C,Rainfray M,Bellera C,Rondeau V,Soubeyran P,Coureau G,Mathoulin-Pélissier S

    更新日期:2018-01-01 00:00:00

  • Older survivors of cancer in the COVID-19 pandemic: Reflections and recommendations for future care.

    abstract:PURPOSE:Although the year after cancer treatment is challenging for all cancer survivors, older adults (≥60 years) face additional challenges due to age-related decline and high rates of comorbidity. There is a paucity of research on how health service interruptions from the COVID-19 pandemic have impacted the experien...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.11.009

    authors: Haase KR,Kain D,Merchant S,Booth C,Koven R,Brundage M,Galica J

    更新日期:2020-12-03 00:00:00

  • Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies.

    abstract:BACKGROUND:The majority of patients with chronic lymphocytic leukemia (CLL) are older and have multiple comorbidities, including other cancer diagnoses. These patients are routinely excluded from participation in clinical trials. OBJECTIVE:In this phase II study, we determined the activity and toxicity of ofatumumab, ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.04.002

    authors: Vitale C,Falchi L,Ciccone M,Burger J,Pemmaraju N,Borthakur G,Wierda WG,Keating MJ,Ferrajoli A

    更新日期:2020-01-01 00:00:00

  • Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.

    abstract:OBJECTIVE:Assess the utility of the G8 screening tool and CGA for older adults with head and neck cancer. METHODS:Patients 65years or older with a primary malignancy of the head and neck region were presented at the multidisciplinary team (MDT) meeting. The Geriatric 8 (G8) questionnaire was administered prior. Clinic...

    journal_title:Journal of geriatric oncology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.jgo.2016.05.006

    authors: Neve M,Jameson MB,Govender S,Hartopeanu C

    更新日期:2016-11-01 00:00:00

  • Aromatase inhibitors: The unexpected breast cancer treatment.

    abstract:OBJECTIVE:Suboptimal adherence with endocrine treatment for breast cancer is influenced by a number of factors but remains poorly understood. We sought to describe the prior knowledge about and expectations of breast cancer treatments among older women retrospecting on their diagnosis and treatment. METHODS:Thematic a...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.024

    authors: Pieters HC,Green E,Sleven M,Stanton AL

    更新日期:2020-04-01 00:00:00

  • Corrigendum to "Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410].

    abstract::The authors regret: A calculation error was corrected in Table 3. As mentioned under the table, the percentage of patients under ‘Baseline’ was calculated from the total no. of patients with geriatric recommendations data (n = 932 pts). This was mistakenly calculated from the number of patients with available GA data ...

    journal_title:Journal of geriatric oncology

    pub_type: 已发布勘误

    doi:10.1016/j.jgo.2016.01.005

    authors: Baitar A,Kenis C,Moor R,Decoster L,Luce S,Bron D,Van Rijswijk R,Rasschaert M,Langenaeken C,Jerusalem G,Lobelle JP,Flamaing J,Milisen K,Wildiers H

    更新日期:2016-03-01 00:00:00

  • Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.

    abstract:OBJECTIVES:Clinical outcomes in older adults with metastatic renal cell carcinoma (mRCC) are poorly understood, particularly in the era of targeted therapies. We characterize survival and relevant treatment-related variables in a modern series. MATERIALS AND METHODS:From an institutional database including 562 patient...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.11.001

    authors: Pal SK,Hsu J,Hsu S,Hu J,Bergerot P,Carmichael C,Saikia J,Liu X,Lau C,Twardowski P,Figlin RA,Yuh BF

    更新日期:2013-04-01 00:00:00

  • Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer.

    abstract:INTRODUCTION:Cognitive impairment (CI) increases chemotherapy toxicity risk with need to understand this association utilizing publicly available short screening tools. We evaluated this utilizing a lower threshold on a short screening tool in older adults with cancer. MATERIALS AND METHODS:We analyzed data from the C...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.10.004

    authors: Jayani RV,Magnuson AM,Sun CL,Ma H,Tew WP,Mohile SG,Gajra A,Klepin HD,Gross CP,Muss HB,Chapman AE,Katheria V,Hurria A,Dale W

    更新日期:2020-03-01 00:00:00

  • Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany.

    abstract:AIMS:To study age-related persistence in postmenopausal women with endocrine-responsive breast cancer treated with tamoxifen (TAM) and aromatase inhibitors (AI). METHODS:Data on 29,245 patients diagnosed with metastatic or non-metastatic breast cancer (BC) and initially treated with TAM or AI between 2004 and 2013 wer...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.03.001

    authors: Jacob L,Hadji P,Kostev K

    更新日期:2016-05-01 00:00:00

  • Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer.

    abstract:OBJECTIVES:Older patients with cancer have increased risk for comorbidity, polypharmacy (PP) and drug related problems (DRP). The aim of this study was to assess the effect of a clinical pharmacist and geriatrician medication review (MR) among older outpatients with cancer to optimize management of comorbidities during...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.07.010

    authors: Choukroun C,Leguelinel-Blache G,Roux-Marson C,Jamet C,Martin-Allier A,Kinowski JM,Le Guillou C,Richard H,Antoine V

    更新日期:2021-01-01 00:00:00